A randomized phase II study comparing induction or consolidation chemotherapy with cisplatin-docetaxel, plus radical concurrent chemoradiotherapy with cisplatin-docetaxel, in patients with unresectable locally advanced non-small-cell lung cancer

S. Senan; F. Cardenal; J Vansteenkiste; J Stigt; F. Akyol; W de Neve; J. Bakker; J.M. Dupont; GV Scagliotti; U. Ricardi; JP van Meerbeeck

doi:10.1093/annonc/mdq388

A randomized phase II study comparing induction or consolidation chemotherapy with cisplatin-docetaxel, plus radical concurrent chemoradiotherapy with cisplatin-docetaxel, in patients with unresectable locally advanced non-small-cell lung cancer

S. Senan, F. Cardenal, J Vansteenkiste, J Stigt, F. Akyol, W de Neve, J. Bakker, J.M. Dupont, GV Scagliotti, U. Ricardi, JP van Meerbeeck

Radiation Oncology

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	553-558
Journal	Annals of Oncology
Volume	22
Issue number	3
DOIs	https://doi.org/10.1093/annonc/mdq388
Publication status	Published - 2011

Access to Document

10.1093/annonc/mdq388

Cite this

Senan, S., Cardenal, F., Vansteenkiste, J., Stigt, J., Akyol, F., de Neve, W., Bakker, J., Dupont, J. M., Scagliotti, GV., Ricardi, U., & van Meerbeeck, JP. (2011). A randomized phase II study comparing induction or consolidation chemotherapy with cisplatin-docetaxel, plus radical concurrent chemoradiotherapy with cisplatin-docetaxel, in patients with unresectable locally advanced non-small-cell lung cancer. Annals of Oncology, 22(3), 553-558. https://doi.org/10.1093/annonc/mdq388

@article{cb8b93e6474c42b9aa3d5b40592e2a1e,

title = "A randomized phase II study comparing induction or consolidation chemotherapy with cisplatin-docetaxel, plus radical concurrent chemoradiotherapy with cisplatin-docetaxel, in patients with unresectable locally advanced non-small-cell lung cancer",

author = "S. Senan and F. Cardenal and J Vansteenkiste and J Stigt and F. Akyol and {de Neve}, W and J. Bakker and J.M. Dupont and GV Scagliotti and U. Ricardi and {van Meerbeeck}, JP",

year = "2011",

doi = "10.1093/annonc/mdq388",

language = "Undefined/Unknown",

volume = "22",

pages = "553--558",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

number = "3",

}

Senan, S, Cardenal, F, Vansteenkiste, J, Stigt, J, Akyol, F, de Neve, W, Bakker, J, Dupont, JM, Scagliotti, GV, Ricardi, U & van Meerbeeck, JP 2011, 'A randomized phase II study comparing induction or consolidation chemotherapy with cisplatin-docetaxel, plus radical concurrent chemoradiotherapy with cisplatin-docetaxel, in patients with unresectable locally advanced non-small-cell lung cancer', Annals of Oncology, vol. 22, no. 3, pp. 553-558. https://doi.org/10.1093/annonc/mdq388

A randomized phase II study comparing induction or consolidation chemotherapy with cisplatin-docetaxel, plus radical concurrent chemoradiotherapy with cisplatin-docetaxel, in patients with unresectable locally advanced non-small-cell lung cancer. / Senan, S.; Cardenal, F.; Vansteenkiste, J et al.

In: Annals of Oncology, Vol. 22, No. 3, 2011, p. 553-558.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - A randomized phase II study comparing induction or consolidation chemotherapy with cisplatin-docetaxel, plus radical concurrent chemoradiotherapy with cisplatin-docetaxel, in patients with unresectable locally advanced non-small-cell lung cancer

AU - Senan, S.

AU - Cardenal, F.

AU - Vansteenkiste, J

AU - Stigt, J

AU - Akyol, F.

AU - de Neve, W

AU - Bakker, J.

AU - Dupont, J.M.

AU - Scagliotti, GV

AU - Ricardi, U.

AU - van Meerbeeck, JP

PY - 2011

Y1 - 2011

U2 - 10.1093/annonc/mdq388

DO - 10.1093/annonc/mdq388

M3 - Article

C2 - 20696676

VL - 22

SP - 553

EP - 558

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

IS - 3

ER -

Senan S, Cardenal F, Vansteenkiste J, Stigt J, Akyol F, de Neve W et al. A randomized phase II study comparing induction or consolidation chemotherapy with cisplatin-docetaxel, plus radical concurrent chemoradiotherapy with cisplatin-docetaxel, in patients with unresectable locally advanced non-small-cell lung cancer. Annals of Oncology. 2011;22(3):553-558. doi: 10.1093/annonc/mdq388